BIO-key International (BKYI) investor relations material

Company overview and business model

• Enterprise IAM provider offering PortalGuard and hosted PortalGuard IDaaS, with 17 authentication factors and biometric identity tools for workforce, customer and civil ID use cases.

• SaaS subscriptions generate annual recurring revenue through noncancelable contracts averaging ~1 year; fees depend mainly on products used and enrolled users, with direct and channel sales.

• Biometric platform supports enrollment, de-duplication and authentication at scale; one bank uses fingerprint biometrics for over 21.7 million customers in branches daily.

• Swivel Secure was acquired in 2022 and now operates as BIO-key EMEA, with offices in Madrid and Lisbon and a direct sales force.

Use of proceeds and capital allocation

• Resale proceeds go entirely to Armistice Capital Master Fund Ltd.; none go to the issuer. Cash exercise of all warrants could yield $5,020,872.08 gross for working capital and general corporate purposes.

• Warrant exercise proceeds depend on Nasdaq-required stockholder approval; cashless exercise would generate no cash. Registration costs are borne by the issuer.

• The August 2026 exercise of existing warrants generated ~$2.5 million gross before fees and expenses; net proceeds were intended for working capital and general corporate purposes.

Risk factors and disclosures

• Resale registration covers shares equal to ~38% of post-exercise outstanding common stock; substantial sales or future issuances could pressure the share price, dilute holders and constrain future equity fundraising.

• Warrants cannot be exercised before stockholder approval; the proposal failed at the September 2026 meeting and was adjourned to October 30, 2026. Repeated approval meetings add costs; approval is not assured.

• Warrants carry a $4.06 exercise price; if market price does not exceed it, cash exercise may not occur. Cashless exercise could issue fewer shares but still materially dilute existing holders.

• Disclosed risks include a history of losses and limited revenue, ability to raise capital and continue as a going concern, competition, security breaches, foreign-market expansion and Nasdaq reporting or listing compliance.

• The auditor's report on FY2025 and FY2024 financial statements includes an explanatory paragraph citing substantial doubt about ability to continue as a going concern; M & K CPAS was engaged in July 2026 after Bush & Associates was dismissed.